Immunology:
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • Humira logo
      Humira logo
      About Humira
      Presentation & Dosing
      Pen Design
      Services
      Resources

      HUMIRA pre-filled Pen – designed with patients in mind1

      au-humira-prefilled-pen-40mg
      Contact a representative
      Contact a representative

      More for you

      AbbVie Care

      AbbVie Care
      How to enrol your patients on HUMIRA
       

      AbbVie Services

      AbbVie Services
      Services and tools to support beyond the consult

      About Rinvoq

      About RINVOQ

       

      References: 1. HUMIRA Consumer Medicine Information. 2. Nash P et al. Rheumatol Ther 2016;3(2):257–70.

      PBS Information

      HUMIRA: Authority required. Refer to PBS Schedule for full authority information. This product is not listed on the PBS for the treatment of enthesitis-related arthritis or paediatric psoriasis.

      Please review the full Product Information (PI) before prescribing, available below.

      HUMIRA PI

      AU-HUM-240082. October 2024